Ferrer Internacional, S.A.;CNIC Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
发明人:
GUERRERO, Marta,ORRIOLS, Anna,MARTIN, Pablo,RAGA, Manuel
申请号：
ES09724677
公开号：
ES2569553T3
申请日:
2009.03.25
申请国别(地区):
ES
年份:
2016
代理人:
摘要：
A capsule comprising: (i) a) w coated tablet (s) comprising 40.5 mg of acetylsalicylic acid and x coated tablet (s) comprising 81 mg of acetylsalicylic acid, where w is a number integer selected between 0 and 1, and x is an integer selected between 0, 1 and 2, such that the total amount of acetylsalicylic acid is 40.5 to 162 mg and w + x is 1 or 2； ob) and coated tablet (s) comprising 50 mg of acetylsalicylic acid and z coated tablet (s) comprising 100 mg of acetylsalicylic acid, where y is an integer selected from 0 to 1, and z is a integer selected from 0, 1 and 2, such that the total amount of acetylsalicylic acid is 50 to 200 mg and y + z is 1 or 2； (ii) a) s coated tablet (s) comprising 20 mg of simvastatin and t coated tablet (s) comprising 40 mg of simvastatin, where s is an integer selected from 0, 1 and 2, and t is an integer selected from 0, 1 and 2, such that the total amount of simvastatin is 20 to 80 mg and s + t is 1 or 2； ob) or coated tablet (s) comprising 20 mg of pravastatin or a pharmaceutically acceptable salt thereof and v coated tablet (s) comprising 40 mg of pravastatin or a pharmaceutically acceptable salt thereof, where u is an integer selected from 0, 1 and 2, and v is an integer selected from 0, 1 and 2, such that the total amount of pravastatin or a pharmaceutically acceptable salt thereof is 20 to 80 mg and u + v is 1 or 2； and (iii) a) p coated tablet (s) comprising 5 mg of lisinopril or a hydrated form, q coated tablet (s) comprising 10 mg of lisinopril or a hydrated form and compressed tablet (s) coated (s) comprising 20 mg of lisinopril or a hydrated form, where p is an integer selected from 0 to 1, q is an integer selected from 0 to 1, and r is an integer selected from 0, 1 and 2 , such that the total amount of lisinopril or the hydrated form is 5 to 40 mg and p + q + r is 1, 2 or 3； b) k coated tablet (s) comprising 2.5 mg of ramipril, m coated tablet (s) comprising 5 mg of ramipril and n coated tablet (s) comprising 10 mg of ramip
